Peng KW - Search Results

1

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H . pylori immunostimulatory bacterial transgene.

Viker KB, Steele MB, Iankov ID, Concilio SC, Ammayappan A, Bolon B, Jenks NJ, Goetz MP, Panagioti E, Federspiel MJ, Liu MC, Peng KW, Galanis E. Viker KB, et al. Among authors: peng kw. Mol Ther Methods Clin Dev. 2022 Jul 31;26:532-546. doi: 10.1016/j.omtm.2022.07.014. eCollection 2022 Sep 8. Mol Ther Methods Clin Dev. 2022. PMID: 36092362 Free PMC article.

2

Intraperitoneal therapy of ovarian cancer using an engineered measles virus.

Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ. Peng KW, et al. Cancer Res. 2002 Aug 15;62(16):4656-62. Cancer Res. 2002. PMID: 12183422

3

Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.

Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC. Phuong LK, et al. Among authors: peng kw. Cancer Res. 2003 May 15;63(10):2462-9. Cancer Res. 2003. PMID: 12750267

4

Biodistribution of oncolytic measles virus after intraperitoneal administration into Ifnar-CD46Ge transgenic mice.

Peng KW, Frenzke M, Myers R, Soeffker D, Harvey M, Greiner S, Galanis E, Cattaneo R, Federspiel MJ, Russell SJ. Peng KW, et al. Hum Gene Ther. 2003 Nov 1;14(16):1565-77. doi: 10.1089/104303403322495070. Hum Gene Ther. 2003. PMID: 14577918

5

Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.

Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E. Allen C, et al. Among authors: peng kw. J Gene Med. 2004 Nov;6(11):1216-27. doi: 10.1002/jgm.616. J Gene Med. 2004. PMID: 15459967

6

Oncolytic activities of approved mumps and measles vaccines for therapy of ovarian cancer.

Myers R, Greiner S, Harvey M, Soeffker D, Frenzke M, Abraham K, Shaw A, Rozenblatt S, Federspiel MJ, Russell SJ, Peng KW. Myers R, et al. Among authors: peng kw. Cancer Gene Ther. 2005 Jul;12(7):593-9. doi: 10.1038/sj.cgt.7700823. Cancer Gene Ther. 2005. PMID: 15746945

7

Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.

Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW. Hasegawa K, et al. Among authors: peng kw. Clin Cancer Res. 2006 Mar 15;12(6):1868-75. doi: 10.1158/1078-0432.CCR-05-1803. Clin Cancer Res. 2006. PMID: 16551872

8

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.

Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ, Russell SJ, LaRusso NF. Blechacz B, et al. Among authors: peng kw. Hepatology. 2006 Dec;44(6):1465-77. doi: 10.1002/hep.21437. Hepatology. 2006. PMID: 17133484

9

Retargeted oncolytic measles strains entering via the EGFRvIII receptor maintain significant antitumor activity against gliomas with increased tumor specificity.

Allen C, Vongpunsawad S, Nakamura T, James CD, Schroeder M, Cattaneo R, Giannini C, Krempski J, Peng KW, Goble JM, Uhm JH, Russell SJ, Galanis E. Allen C, et al. Among authors: peng kw. Cancer Res. 2006 Dec 15;66(24):11840-50. doi: 10.1158/0008-5472.CAN-06-1200. Cancer Res. 2006. PMID: 17178881

10

Engineering oncolytic measles virus to circumvent the intracellular innate immune response.

Haralambieva I, Iankov I, Hasegawa K, Harvey M, Russell SJ, Peng KW. Haralambieva I, et al. Among authors: peng kw. Mol Ther. 2007 Mar;15(3):588-97. doi: 10.1038/sj.mt.6300076. Epub 2007 Jan 16. Mol Ther. 2007. PMID: 17245355 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

182 results

Search Page